The study aimed to compare the reported oncological outcomes based on satisfactory lymph node dissection (LND) or lymph node sampling (LNS), systemic and loco-regional recurrence rate and long-term survival rate of patients with early-stage non-small-cell lung cancer (NSCLC) who underwent video-assisted thoracic surgery (VATS) lobectomy or thoracotomy lobectomy. A systematic review was conducted using PubMed, EMBASE and OVID-EBMR databases ranging from 1990 to 2011. The studies compared VATS and thoracotomy for patients with NSCLC, with results including LND or LNS where recurrence as well as survival rates were identified. Data were abstracted by two reviewers independently. Mean difference or risk ratio (RR) were pooled using RevMan 5.0 statistical software. 5389 cases were included, of which 2380 underwent VATS and 3009 underwent thoracotomy. There was no significant difference in the number of total LND or LNS procedures (MD: −0.63; 95% confidence intervals (95% CI): −1.47 to 0.21; P = 0.14) or mediastinal LND or LNS (MD: −0.51; 95% CI: −1.58 to 0.56; P = 0.35) between the two groups. Systemic (RR: 0.61; 95% CI: 0.48 to 0.78; P < 0.01) and loco-regional (RR: 0.66; 95% CI: 0.46 to 0.95; P = 0.03) recurrence rates were significantly lower in the VATS group. Moreover, a significantly higher survival rate (RR: 1.09; 95% CI: 1.03 to 1.15; P < 0.01) was also demonstrated by a Forest plot in the VATS group. These results suggest that VATS lobectomy might be an eligible alternative in place of thoracotomy in patients with early-stage NSCLC by reducing recurrence and improving survival rates.
INTRODUCTION
Video-assisted thoracic surgery (VATS) lobectomy is becoming the preferred surgical procedure for early-stage non-small-cell lung cancer (NSCLC) [1] since it was first reported by Raviaro [2] . Prior studies have outlined the various benefits of VATS over thoracotomy including less morbidity, less immunosuppression and better long-term survival rates [3] [4] [5] . However, the oncological outcome remains controversial [5] , which is affecting the widespread acceptance of VATS. Major opponents of VATS have insisted that this procedure has some disadvantage in en-bloc resection and lymph node dissection (LND), which might increase the loco-regional recurrence rate [6, 7] .
The oncological outcome of VATS lobectomy for earlystage NSCLC, including LND or lymph node sampling (LNS), systemic recurrence rate, loco-regional recurrence rate and longterm survival rate were evaluated in this meta-analysis.
METHODS

Selection criteria
Comparative studies using LND or LNS, recurrence rates or survival rate in both the VATS and the thoracotomy groups for NSCLC were included. Studies that enrolled either >20% nonlobectomy procedures or >10% neoadjuvant therapies were excluded. Also, studies with inextractable data were excluded. If more than one study's data could be retrieved to the same cases, only the latest one or the one with the most complete data was included. Only articles published in English were included.
American College of Physicians Journal Club, ACP Journal Club, Database of Abstracts of Reviews of Effects, Cochrane Central Register of Controlled Trials, Cochrane Methodology Register, Health Technology Assessment, and NHS Economic Evaluation Database) was conducted from January 1990 to December 2011. The Text words and Mesh terms 'lung cancer', 'thoracotomy', 'video-assisted thoracic surgery' and comparative study were used. Related articles on the reference lists of the manuscripts were also searched for further relevant studies.
Data extraction
Two investigators independently identified the publications based on title and abstract, using predefined inclusion and exclusion criteria. Any disagreement was arbitrated by a third investigator. Full text of potentially relevant publications were obtained and re-evaluated by the same investigators. From these relevant publications, the following data were extracted from eligible articles: first author, year of publication, nation, study design, patients' enrolment date, number of patients in each group and characteristics such as clinical stage, histological and pathological stage, LND or LNS number, systemic recurrence rate, loco-regional recurrence rate and survival rate.
Validity assessment
Newcastle-Ottawa Scale (NOS) was employed to identify the quality and bias of the primary non-randomized studies by two assessors [8] . A 'star system' was used to evaluate the quality of a study following three broad perspectives: selection of study groups; comparability of the groups and ascertainment of either the exposure or outcome of interest for case-control or cohort studies, with a maximum of 9 stars. Studies were graded as good quality with 8-9, fair with 5-7, and poor with <5 stars.
Randomized controlled trials were assessed based upon the Jadad scale [9] . This 5-point scale contained questions for randomization, masking, withdrawals and dropouts. Studies were considered as good quality if ≥3 points were present.
Statistical analysis
Meta-analysis was conducted using Review Manager 5.0 software (The Nordic Cochrane Centre, The Cochrane Collaboration, Copenhagen, Denmark). For continuous outcomes, mean difference weighed by inverse of the variance was calculated. For dichotomous variables, the relative risk (RR) between two groups with 95% confidence intervals was calculated. The Cochrane's Q and I 2 statistics were calculated to assess the heterogeneity. Fixed-effects models were adopted if the level of heterogeneity was acceptable (P > 0.10, or P ≤ 0.10 but I 2 ≤ 50%); otherwise, random-effects model were adopted. Sensitivity analyses were undertaken to evaluate the robustness of the survival rate for studies that followed up a period of <5 years. A two-tailed P-value ≤0.05 was deemed statistically significant.
For some studies, original data were re-calculated for analysis. Publication bias was explored through visual inspection of the funnel plots.
RESULTS
Description of studies
One thousand and ninety-nine publications were initially identified from the searches of databases and reference lists. Twenty-one articles [6, 7, [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] were reviewed for final analysis (Fig. 1) . A total of 5389 patients were included of whom 2380 patients underwent VATS and 3009 patients underwent thoracotomy. Of these 21 publications, two studies were randomized, controlled trials (RCTs) [10, 13] . Baseline characteristics of these patients are listed in Tables 1 and 2 .
The quality of the studies was generally good according to the assessment score of NOS and Jadad scales.
Lymph node dissection or lymph node sampling
Seven [7, 10, 12, 14, 17, 18, 27] and four [7, 11, 13, 17] articles were available for total and mediastinal LND or LNS number analysis, respectively. The mean difference of total LND or LNS numbers between the two groups was not significant (−0.63; 95% CI: −0.47 to 0.21; P = 0.14). The heterogeneity in related studies was at an acceptable level (P = 0.10, I 2 = 44%). The difference in mediastinal LND or LNS numbers between the two groups was also negligible (−0.51; 95% CI: −1.58 to 0.56; P = 0.35), with significant heterogeneity across studies (P = 0.04, I 2 = 65%) (Fig. 2 ).
Recurrence rate
The recurrence rate was available in 10 [13, 15-20, 25, 26, 28] articles. Pooled results showed that both systemic (RR = 0.61; 95% CI: 0.48 to 0.78; P < 0.01) and loco-regional (RR = 0.66; 95% CI: 0.46 to -0.95; P = 0.03) recurrence rates were significantly lower in the VATS group, without evidence of heterogeneity (P = 0.67, I 2 = 0% and P = 0.46, I 2 = 0%, respectively) ( Fig. 3 ).
Survival rate
Of the 13 [6, 7, 13, 15, 16, [18] [19] [20] [21] [22] [23] [24] 28] articles included, the survival rate demonstrated by the Forest plot was significantly higher (RR = 1.09; 95% CI: 1.03 to 1.15; P < 0.01) in the VATS group. The included studies were heterogeneous (P < 0.01, I 2 = 63%). After exclusion of the four [6, 7, 22, 28] studies where the follow-up period was 3 or 4 years, the heterogeneity disappeared (P = 0.08, I 2 = 44%). There was a slight adjustment in overall effect, but the final results remained the same (RR = 1.10; 95% CI: 1.04 to 1.17; P < 0.01) (Fig. 4) .
Publication bias
A funnel plot may be seen, which arises from the fact that the precision of the estimated effect improved by the scale of the study. Estimated effects from small-scale studies scatter more widely at the bottom of graph, while larger scale studies show a tight distribution at the top. The plot resembles a symmetrical and inverted funnel if the analysis has no publication bias. Our results indicated that publication bias might exist based on the data of recurrence rates (Fig. 5) .
DISCUSSION
Though VATS is associated with many benefits compared with thoracotomy, there is still controversy as to whether VATS lobectomy could reduce the local recurrence rate and improve the long-term survival rate in patients with early-stage NSCLC [29] . Therefore, we carried out this meta-analysis of randomized and non-randomized trials to assess the effects of VATS lobectomy for resectable NSCLC.
The meta-analysis showed a statistically better survival rate and lower systemic and loco-regional recurrence rates in the VATS group than the thoracotomy group. No difference was found in both total and mediastinal LND or LNS numbers between the two groups. Similar results could be found in another meta-analysis published in 2009 [30] , but without the results of LND and LNS. However, satisfactory LND or LNS affect recurrence and survival rates significantly. Hence in this analysis, we focused on LND or LNS as one of the important features of the oncological outcome. Also, several recent studies were included in this analysis.
Lymph node dissection or lymph node sampling LND or LNS procedures and their outcomes varied between centres, because there were different opinions about LN dissection for lung cancer procedures [31] . Limitation of technical expertise, surgeons' will [23] , and effect of learning curve [32] might influence these procedures. In 2006, the European Society of Thoracic Surgeons (ESTS) published guidelines for LND or LNS and suggested that at least three N1 LN and three N2 LN from three stations should be removed for NSCLC [33] .
Our results suggested that total and mediastinal LN numbers were comparable between the VATS group and the thoracotomy group. Unfortunately, we were unable to obtain the results of the LN station number. At the beginning, both LN number and station were concerned. During the review of all potentially relevant papers, we found five studies [23, [34] [35] [36] [37] mentioning LN station comparison but only two of them could be identified [34, 37] . This made LN station analysis impossible. These two articles showed different results. In Ilonen's [34] study, more LN stations were sampled in the thoracotomy group, but in D'Amico's study [37] , there was no difference in the efficacy of MLN dissection by VATS or by thoracotomy. Thus, to compare the efficacy of LND or LNS by VATS or thoracotomy, more randomized controlled studies on LN station number are needed. 
Recurrence rate
Concerns on the possibility of technique-dependent recurrence rate in VATS lobectomy puzzled many surgeons, who considered factors such as cancer dissemination during manipulation, insufficient surgical margin or LN dissection affected the recurrence rate. Yan [30] showed that there was no significant statistical difference with loco-regional recurrence, but a significant difference was found with systemic recurrence in the VATS group. Flores [26] undertook a retrospective cohort study to evaluate recurrence difference, and his results showed that both loco-regional and systemic recurrence rates were lower in the VATS group. Our analysis showed results similar to that of Flores' study. These results may eliminate some apprehension about the technique-dependent recurrence rate related to VATS. However, it should be fully noticed that not only technical advantage but also histology [26, 38] and pathological stage [26] could influence the systemic recurrence rate. Relative risks for systemic and loco-regional recurrence rates in VATS group as compared to the thoracotomy group. Note: When both loco-regional and systemic metastasis occurred synchronously in patients, they were classified under the systemic metastasis group [16, 26, 28] . 
Survival rate
Recently, several reports have shown favourable or at least equivalent short-term and long-term survival rate from VATS [13, 15, 16, [18] [19] [20] [21] [22] [23] [24] [25] 28 ] compared with thoracotomy. Our analysis further showed a better survival rate following VATS compared with thoracotomy. After exclusion of four [6, 7, 22, 28] studies that only reported short-term survival, the trend remained, and it was concluded that several reasons might contribute to this result. First, VATS could improve the tolerance of postoperative chemotherapy, which could prove beneficial to their survival [27, 39, 40] , though this benefits could be minimal because most of enrolled cases are pathological stage I and especially pathological stage IA patients for whom postoperative chemotherapy is not indicated. Also, less trauma, cytokine production and consequent immunological advantages in the VATS group could also improve survival rates [41] . However, the current clinical data are insufficient to determine whether the survival predominance was due to VATS since not only VATS, but also other factors such as histology [42] , diameter of the tumor, pathological stage [23] , and selection bias might lead to survival differences. Thus, the survival superiority of VATS needs to be interpreted more discreetly. Meanwhile, in several studies, the converted cases in the thoracotomy group [6, 13, 19, 20, 24] might have also influenced the survival rate because the conversions were likely to be on more advanced stage cancers, and the procedure could prove to be more technically difficult. As the 7th TNM staging system made many revisions that reflected the prognosis of patients, if all patients enrolled in this analysis are restaged with the 7th staging system rather than the 6th edition, there might be many restaged cases. Therefore, these results might be different because patients with smaller tumors may have been in the VATS group [6, 13, 14, 17, [19] [20] [21] .
Several limitations of this meta-analysis should be considered. First, meta-analysis may be constrained by the strategy of the searches, selection criteria and publication bias, especially when the meta-analysis was conducted on the epidemiological studies rather than randomized controlled trials. To minimize these risks, we carried out thorough searches across different databases with explicit selection criteria and meticulous data abstraction. Second, bias may have been introduced because most studies were from the USA or Japan. In addition, only studies published in English were included. Third, some studies that characterized LN or LN station number did not report standard deviation and variation could not be included in our meta-analysis, even though a significant difference was found between two groups. This issue might affect the results of our meta-analysis. Finally, most studies involved were prospective studies published from existing literature, so these results should be interpreted cautiously due to the selection bias.
In conclusion, our analysis suggests that VATS lobectomy could achieve satisfactory results in recurrence and survival rates. However, this analysis could not conclude whether VATS could provide comparable LND or LNS efficacy with thoracotomy. It suggests that VATS might be an eligible alternative therapy to thoracotomy in patients with early-stage NSCLC.
